Piper Sandler Reaffirms Neutral Rating for Alpha Tau Medical (NASDAQ:DRTS)

Piper Sandler Reaffirms Neutral Rating for Alpha Tau Medical (NASDAQ:DRTS)

Alpha Tau Medical (NASDAQ:DRTS – Get Free Report)‘s stock had its “neutral” rating reissued by equities research analysts at Piper Sandler in a research report issued to clients and investors on Wednesday, Marketbeat.com reports. They currently have a $5.00 price target on the stock. Piper Sandler’s price target would suggest a potential downside of 29.78% from the stock’s current price. A number of other analysts also recently issued reports on…